Experience the transformation a 30% reduction in fat cell size and over 40% reduction in fat cell volume
Because AOD9604 does not stimulate IGF-1 production and lacks strong GH receptor agonism, it may present a safer alternative for long-term OA treatment [1]
Easy measuring: At 12.5 mg/mL, 1 unit = 0.01 mL = 0.125 mg (125 mcg) on a U-100 insulin syringe
Goodman says, though some people require them for the long term. Your healthcare provider will make recommendations based on your B12 level, age, diet and overall health
First, AOD-9604 activates beta-3 adrenergic receptors on fat cells, triggering the cAMP-PKA cascade that activates hormone-sensitive lipase
For the average adult seeking to maintain healthy levels or boost energy, a single injection once a month is often the standard protocol